Multifunctional Roles and Microbial Production Bottlenecks of Ergothioneine

View at publisher
Authors: Zhi Ma, Chen Qin, Yanfeng Deng, Xinying Guo, Linjiang Zhu, Dianhao Zhu, Xiaolong Chen
Cited by: 1
References: 123

Abstract

Ergothioneine (EGT) is a unique natural chiral compound endowed with potent antioxidative, anti-inflammatory, and cytoprotective properties. Currently, EGT is primarily produced via bioextraction from mushrooms and chemical synthesis; however, the low efficiency and high costs associated with these methods hinder their ability to meet the growing market demand. Consequently, heterologous EGT production in non-native host strains (e.g., Escherichia coli and Corynebacterium glutamicum ) has garnered increasing attention. With the rapid advancement of synthetic biology and metabolomics, remarkable progress has been achieved in EGT production in recent years, with the high titers have reached 7.2 g/L in E. coli and 9.3 g/L in Yarrowia lipolytica . Meanwhile, the development of a “chemoenzymatic catalytic cascade″ route has achieved the highest titer: 47.3 g/L. This review focuses on the latest advances in the discovery and identification of key enzymes involved in EGT biosynthetic and catabolic pathways and metabolic engineering strategies for EGT production. Additionally, the multifunctional roles and practical applications of EGT in the food, cosmetics, and pharmaceutical industries are summarized.

Fields of Study & Subjects

Fungal Biology and Applications Microbial Metabolic Engineering and Bioproduction Microbial Natural Products and Biosynthesis

Publication details

Journal / source
ACS Synthetic Biology
Publisher
American Chemical Society (ACS)
Volume
15
Issue
4
Pages
1249–1263
Publication date
1 April 2026
Language
EN